SHLT Rasio cepet SHL Telemedicine

SHL Telemedicine Ltd. relies on its own centers in Europe and Israel to provide remote cardiac monitoring and medical support. Business growth is driven by expansion in Western markets, a broadening client base, and demographic shifts. The current ratio is 1.97. The price chart for SHLT reflects the dynamics of a defensive asset that operates in an autonomous cycle, independent of global economic fluctuations.

To assess the fundamental stability of SHL Telemedicine Ltd. (SHLT), investors must understand the company's ability to meet its immediate obligations. This metric is calculated as the sum of cash and accounts receivable minus inventories, as reflected in the annual quick liquidity trend. The current value of 1.97 demonstrates the business's real margin of safety. Such a financial reserve is critically important for SHL Telemedicine Ltd. (SHLT) when scaling heart monitoring in the US market.